<DOC>
	<DOCNO>NCT02226484</DOCNO>
	<brief_summary>Purpose : 1 . Determine oral quercetin increase expression claudin-4 lining esophagus patient diagnosis gastroesophageal reflux disease ( GERD ) ; 2 . Determine whether increase claudin-4 oral quercetin accompany improvement barrier function acid resistance line esophagus patient diagnosis gastroesophageal reflux disease ( GERD ) If interested , participant consent provided questionnaire complete part study . Participants undergo endoscopy routine care 8 esophageal biopsy ( small tissue sample ) take research study . After endoscopy , participant contact begin 6 week treatment period study drug ( Quercetin , take twice daily ) . At end 6 week period , participant schedule blood drawn follow-up endoscopy biopsy perform research study .</brief_summary>
	<brief_title>Can Quercetin Increase Claudin-4 Improve Esophageal Barrier Function GERD ?</brief_title>
	<detailed_description>Patients must symptomatic ( heartburn ) agree allow endoscopic biopsy low 5 cm esophagus research purpose . If endoscopy demonstrate non-erosive reflux disease , biopsy Esophageal Squamous Epithelium ( ESE ) obtain place mRNA-Later assess claudin-4 mRNA qRT-PCR protein expression Western blot ( 53 , 64 ) biopsy ESE obtain handle SpAim # 2 assess barrier function ESE . After consent , subject complete questionnaire assess demographic , disease-specific parameter duration symptom past treatment , gastroesophageal reflux disease ( GERD ) Symptom Assessment Scale ( GSAS ) , validated measure GERD severity . Following , patient open label fashion give orally 500 mg Quercetin ( Q ) twice daily ( bid ) [ Pure , House Nutrition , Yonkers , NY ] 6-weeks . Symptoms monitor 1 week 6 week treatment period . At 6 week , blood sample obtain determination Q metabolites HPLC endoscopy biopsy ESE repeat process initially do claudin-4 level ESE .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Quercetin</mesh_term>
	<criteria>English speaking Able read , comprehend , complete consent form . Aged 18 80 Diagnosed gastroesophageal reflux disease ( GERD ) physician , define : . History heartburn &gt; 3 times/week &gt; 4 month AND either : i. Abnormal 24hrpH monitoring ( acid contact time &gt; 4.5 % OR ii . Past responsiveness proton pump inhibitor ( PPI ) therapy Willing undergo esophageal biopsy , endoscopy , take study medication . Willingness discontinue remain PPIs duration study ( rescue medication use study antacid H2 blocker need symptom permit ) Patients medical condition make him/her poor risk upper endoscopy , conscious sedation , esophageal biopsy ability comply study directives Current use blood thinner coumadin , warfarin , heparin and/or low molecular weight heparin , rivaroxaban ( require discontinuation medication 5 day prior 6 day EGD ) Patients know bleed disorder Patients status post partial complete esophageal resection Patients history esophageal gastric surgery , include fundoplication , gastric bypass , etc . Patients history esophageal varix , esophageal cancer , achalasia , Barrett 's esophagus , eosinophilic esophagitis , Current diagnosis invasive esophageal cancer Current use calcium channel blocker , estradiol , immune suppressive drug , aspirin , nonsteroidal antiinflammatory drug ( NSAIDs ) , antibiotic , and/or taxol/paclitaxel Pregnant woman Patients history intolerant Quercetin Patients continue moderate severe heartburn despite use twice daily PPIs ( i.e . refractory twice daily dose PPIs ) Patients current active erosive esophagitis ( assessed baseline EGD ) . Patients history erosive esophagitis require PPI treat . However , patient history erosive esophagitis discontinue PPI therapy least 3 month prior baseline EGD , erosive disease see baseline EGD , patient eligible . Patients significant erosive gastropathy baseline EGD require PPI treat clinically .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Acid reflux</keyword>
	<keyword>Reflux</keyword>
	<keyword>Quercetin</keyword>
</DOC>